Myriad Genetics Announces Second Quarter Fiscal 2008 Financial Results Conference Call

Tuesday, February 5, 2008 at 10:00 a.m. ET

Salt Lake City, UT, Jan 22, 2008—Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: February 5, 2008
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID# 32258334
(Please dial in approximately 10 minutes before the call is scheduled to begin)

A press release will be issued at 6:30 am ET.

Replay of the call will be available from two hours after the call for seven days by dialing (800) 642-1687 or (706) 645-9291, and entering the conference ID number.

A live audio Webcast will be available at: www.myriad.com.